Bioresorbable vascular scaffold (BVS) for in-stent chronic total occlusion: Antegrade recanalization and IVUS-guided BVS implantation by radial access

Massimo Medda, Francesco Casilli, Marta Bande, Maria Giulia Latini, Mehdi Ghommidh, Francesca Del Furia, Luigi Inglese

Research output: Contribution to journalArticlepeer-review

Abstract

The completely absorbable stents represent one of the latest innovations in the field of interventional cardiology, prospecting the possibility of "vascular repair". In the published trials (ABSORB Cohort A and B, ABSORB EXTEND, and ABSORB II, III and IV) chronic total occlusions (CTOs) were considered an exclusion criteria. More recently the CTO-ABSORB pilot study demonstrated the safety and feasibility of bioresorbable vascular scaffold (BVS) use in case of CTO recanalization. We present the first case, to our knowledge, of in-stent occlusion successfully treated with an everolimus-eluting BVS and discuss its potential advantages in such kind of lesions.

Original languageEnglish
Pages (from-to)63-65
Number of pages3
JournalCardiovascular Revascularization Medicine
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Keywords

  • Bioresorbable vascular scaffold (BVS) implantation
  • Chronic total occlusion (CTO)
  • Intravascular ultrasound (IVUS)
  • Restenosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Bioresorbable vascular scaffold (BVS) for in-stent chronic total occlusion: Antegrade recanalization and IVUS-guided BVS implantation by radial access'. Together they form a unique fingerprint.

Cite this